首页> 美国卫生研究院文献>Medicina >The Administration of the New Pyrimidine Derivative—4-{2-2-(34-Dimethoxyphenyl)-Vinyl-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il}Benzsulfamide Restores the Activity of Brain Cells in Experimental Chronic Traumatic Encephalopathy by Maintaining Mitochondrial Function
【2h】

The Administration of the New Pyrimidine Derivative—4-{2-2-(34-Dimethoxyphenyl)-Vinyl-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il}Benzsulfamide Restores the Activity of Brain Cells in Experimental Chronic Traumatic Encephalopathy by Maintaining Mitochondrial Function

机译:施用新的嘧啶衍生物-4- {2- 2-(2-(34-二甲氧基苯基)-乙烯基 -6-乙基-4-氧代-5-苯基-4H-嘧啶-1-Il}苯磺酰胺可恢复维持线粒体功能在实验性慢性创伤性脑病中脑细胞的活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background and objectives: To evaluate the effect of a new pyrimidine derivative on the change of mitochondrial function in experimental chronic traumatic encephalopathy. Materials and methods: The study was performed on male mice of the BALB/c line (acute toxicity was assessed) and male rats of the Wistar line, which were modeled chronic traumatic encephalopathy by the method of free fall of the load (weight 150 g from a 50 cm height). The injury to rats was reproduced once a day for 7 days. Further, cognitive functions, changes in sensorimotor deficiency, cerebral blood flow, neuron-specific enolase(NSE), S100β, glial fibrillary acidic protein (GFAP) (in blood serum) and β-amyloid, adenosine triphosphate (ATP) (in brain tissue supernatant) were evaluated. Mitochondrial respiration was also measured. Choline alfoscerate (100 mg/kg) was used as a reference drug. Results: The study found that the use of a new pyrimidine derivative contributed to the preservation of the mitochondrial respirometric function and cognitive functions in rats. In addition, against the administration of test-object marked increase in the concentration of ATP, the velocity of cerebral blood flow was 4.2 times (p < 0.05) and 35.6% (p < 0.05), respectively, as well as reduced concentration and GFAP, NSE, S100β, β-amyloid and sensorimotor deficit at 2.7 (p < 0.05) times; 2 times (p < 0.05); 2.4 times (p < 0.05); of 30.4% (p < 0.05 and 46.5% (p < 0.05), respectively. The LD50 (per os) for the test-object was 4973.56 ± 573.72 mg/kg. Conclusion: Based on the obtained data, high therapeutic efficacy and low systemic toxicity of the application are assumed 4-{2-[2-(3,4-dimethoxyphenyl)-vinyl]-6-ethyl-4-oxo-5-phenyl-4H-pyrimidine-1-Il}benzsulfamide in chronic traumatic encephalopathy.
机译:背景与目的:评价新型嘧啶衍生物对实验性慢性外伤性脑病线粒体功能变化的影响。材料和方法:这项研究是针对BALB / c系的雄性小鼠(评估急性毒性)和Wistar系的雄性大鼠进行的,它们通过负荷的自由落体(重150 g)模拟慢性创伤性脑病从50厘米高)。对大鼠的伤害每天重复一次,持续7天。此外,认知功能,感觉运动不足的变化,脑血流量,神经元特异性烯醇化酶(NSE),S100β,神经胶质纤维酸性蛋白(GFAP)(在血清中)和β-淀粉样蛋白,三磷酸腺苷(ATP)(在脑组织中)评价)。还测量了线粒体呼吸。磷胆碱(100 mg / kg)用作参考药物。结果:研究发现使用新的嘧啶衍生物有助于维持大鼠线粒体呼吸测定功能和认知功能。此外,在不增加被测物的ATP浓度的情况下,脑血流速度分别为4.2倍(p <0.05)和35.6%(p <0.05),以及降低的浓度和GFAP ,NSE,S100β,β-淀粉样蛋白和感觉运动功能障碍是2.7(p <0.05)倍; 2次(p <0.05); 2.4倍(p <0.05);分别为30.4%(p <0.05和46.5%(p <0.05)。受试对象的LD50(每os)为4973.56±573.72 mg / kg。结论:根据获得的数据,治疗效果高且低假定该应用具有全身毒性,在慢性创伤中使用4- {2- [2-(2-(3,4-二甲氧基苯基)-乙烯基] -6-乙基-4-氧代-5-苯基-4H-嘧啶-1-Il}苯磺酰胺脑病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号